01 1Samsung Bioepis Co., Ltd
02 5Samsung Bioepis Co., Ltd.
03 4Samsung Biologics Co., Ltd.
01 2No Action Indicated
02 8Voluntary Action Indicated
01 12024-11-22
02 22023-09-15
03 12023-09-01
04 12023-02-28
05 12019-11-01
06 12019-02-15
07 12018-06-26
08 12018-04-06
09 12016-08-19
01 1Suwon
02 5Yeonsu
03 4Yeonsu District
01 10South Korea
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-11-22
City : Yeonsu
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-11-22
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-09-15
City : Yeonsu
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-09-15
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-09-15
City : Yeonsu
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-09-15
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-09-01
City : Yeonsu District
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-09-01
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-02-28
City : Yeonsu District
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Blood and Blood Products
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-02-28
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-11-01
City : Yeonsu District
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-11-01
District Decision : No Action Indicated
Inspection End Date : 2019-02-15
City : Yeonsu
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2019-02-15
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-06-26
City : Yeonsu District
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-06-26
District Decision : No Action Indicated
Inspection End Date : 2018-04-06
City : Suwon
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2018-04-06
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-08-19
City : Yeonsu
State :
Country/Area : South Korea
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-08-19
Samsung Biologics is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Infliximab bulk offered by Samsung Biologics
Find a price of Telavancin Hydrochloride bulk offered by Samsung Biologics
